Antibodies targeting MUSK, which we found to be elevated in DS and associated with co-occurring neurological phenotypes (Figure 1g–h), have been linked to development of myasthenia gravis, a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles (Dresser et al., 2021). The gene discussed is MUSK; the disease is myasthenia gravis.